microRNAs in Tumor Microenvironments

A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Molecular Genetics and Genomics".

Deadline for manuscript submissions: closed (20 March 2021) | Viewed by 3075

Special Issue Editors


E-Mail Website
Guest Editor
Department of Biomedical and Biotechnological Sciences, Universita degli Studi di Catania, Catania, Italy
Interests: general pathology; oncology; cancer development; drug resistance; epigenetics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The tumor microenvironment, including cancer-associated fibroblasts (CAF), cancer-infiltrating cells, blood vessels, inflammatory cells, and several other molecules, is one of the main players involved in the development and progression of tumors. It has been widely demonstrated that the mutual interaction between cancer cells and normal cells of the tumor microenvironment is responsible for the production of proinflammatory cytokines and proteolytic proteins which favor tumor invasion and metastasis. Several studies have attempted to understand the molecular mechanisms involved in cell–cell interactions, focusing attention on epigenetic regulation of the tumor microenvironment. In this context, a growing body of evidence shows that microRNAs (miRNAs), a class of small noncoding RNAs, are actively involved in  alterations to signal transduction and in the regulation of the cancer cell tumor environment/stroma communication. In particular, the mutual interaction between miRNAs and the tumor microenvironment was established. In fact, miRNAs released from cancer cells are able to alter the homeostasis of the tumor microenvironment; by contrast, tumor microenvironment miRNAs are able to alter gene expression in cancer cells.

On these bases, it is evident that miRNAs are fundamental in the regulation of the tumor microenvironment and, in turn, the progression of cancer. Therefore, further studies are needed to better understand the dynamics between miRNAs, cancer cells, and the tumor microenvironment in order to identify new diagnostic and prognostic biomarkers as well as new therapeutic targets.

The aim of this Special Issue is to summarize the current understanding about the evaluation of molecular and epigenetic mechanisms responsible for alterations in the tissue microenvironment and, in particular, the mutual interactions existing between cancer and stromal cells as mediated by miRNAs.

Potential topics will include, but are not limited to:

  • Epigenetic modifications of the tumor microenvironment.
  • miRNAs and cancer cell tumor environment/stroma communication.
  • miRNA molecular trafficking in tumor microenvironment.
  • Alteration of signal transduction by miRNAs and consequences for tumor progression.
  • miRNAs as predictive biomarkers of tumor invasion.
  • Liquid biopsy and high-throughput technologies for the analysis of miRNAs.
  • Interaction of miRNA and tumor microenvironment.
  • Inflammatory and immune modulation of tumor microenvironment mediated by miRNAs
  • miRNAs as therapeutic targets for invasive tumors.

Prof. Massimo Libra
Guest Editor

Dr. Luca Falzone
Assistant Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • microRNAs
  • cancer
  • epigenetics
  • tumor microenvironment
  • liquid biopsy

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 2668 KiB  
Article
Analysis of Gene Expression of miRNA-106b-5p and TRAIL in the Apoptosis Pathway in Gastric Cancer
by Jéssica Pereira, Mônica Santos, Roger Delabio, Mônica Barbosa, Marília Smith, Spencer Payão and Lucas Rasmussen
Genes 2020, 11(4), 393; https://0-doi-org.brum.beds.ac.uk/10.3390/genes11040393 - 05 Apr 2020
Cited by 5 | Viewed by 2692
Abstract
Helicobacter pylori (H. pylori) is one of the main causes of gastric gancer. TNF-related apoptosis-inducing ligand (TRAIL) is a protein able to promote apoptosis in cancer cells, however not in gastric cancer, which presents resistance to apoptosis via TRAIL. It [...] Read more.
Helicobacter pylori (H. pylori) is one of the main causes of gastric gancer. TNF-related apoptosis-inducing ligand (TRAIL) is a protein able to promote apoptosis in cancer cells, however not in gastric cancer, which presents resistance to apoptosis via TRAIL. It is believed that MicroRNA-106b-5p might be involved in this resistance, although its role in Gastric Cancer is unclear. We aimed to determine the expression of microRNA-106b-5p and TRAIL in patients with gastric diseases, infected by H. pylori, and understand the relationship between these genes and their role in apoptosis and the gastric cancer pathways. H. pylori was detected by PCR, gene expression analysis was performed by real-time-qPCR, and bioinformatics analysis was performed using the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Cytoscape software. A total of 244 patients were divided into groups (Control, Gastritis, and Cancer); H. pylori was detected in 42.2% of the samples. The cancer group had a poor expression of TRAIL (p < 0.0001) and overexpression of microRNA-106b-5p (p = 0.0005), however, our results confirmed that these genes are not directly related to each other although both are apoptosis-related regulators. Our results also indicated that H. pylori decreases microRNA-106b-5p expression and that this is a carcinogenic bacterium responsible for gastric diseases. Full article
(This article belongs to the Special Issue microRNAs in Tumor Microenvironments)
Show Figures

Figure 1

Back to TopTop